skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8129

Efficacy of language assessment in Alzheimer's disease: comparing in-person examination and telemedicine

(2462) Views  (399) Full article downloads

Authors: Lindsey Vestal, Laura Smith-Olinde, Gretchen Hicks, Terri Hutton, John Hart Jr

Published Date February 2006 Volume 2006:1(4) Pages 467 - 471
DOI: http://dx.doi.org/10.2147/CIA.S

Lindsey Vestal1, Laura Smith-Olinde1, Gretchen Hicks1, Terri Hutton1, John Hart Jr1–3
 

1Department of Speech Pathology, University of Arkansas at Little Rock; 2GRECC of CAVHS, Little Rock, AR, USA; 3Center for BrainHealth, University of Texas at Dallas, Dallas, TX, USA

Background: With the large number of aging individuals requiring screening of cognitive functions for dementing illnesses, there is a necessity for innovative evaluation approaches. One domain that should allow for online, at a distance, examination is speech and language dysfunction, if the auditory and visual transmission is of sufficient quality to allow adequate patient participation and reliable, valid interpretation of signs and symptoms (Duffy et al 1997).

Objective: Examine the effectiveness of language assessment in mild Alzheimer’s patients using telemedicine (TM) compared with traditional in-person (IP) assessment.

Design: Ten patients with mild Alzheimer’s disease, enrolled at a Geriatric Memory Clinic received a battery of standard language tests under two conditions: face-to-face and via satellite TM.

Results: Comparison of TM and IP testing conditions were assessed within each for scores on each test in the two conditions. On each of the five language tasks, the Wilcoxon signed ranks test indicated no significant difference on performance between the TM and IP conditions for each participant. Overall acceptance of the TM evaluation in an elderly population was rated at a high level except for one individual.

Conclusion: Telemedicine can improve access to speech and language evaluation services which is relevant to both dementia and other neurological diseases of the elderly. In particular, this specific assessment tool can be used to provide evaluations in under-served rural areas.